Literature DB >> 11127474

Is the prognosis of heart failure improving?

A Khand1, I Gemmel, A L Clark, J G Cleland.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11127474     DOI： 10.1016/s0735-1097(00)00995-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  29 in total

1.  Limitations of the use of clinical trial results in managing heart failure in the African-American community: a time for active participation in generating applicable data.

Authors:  Joseph A Franciosa
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

Review 2.  Hibernation and heart failure.

Authors:  P G Camici
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 3.  Contemporary management of heart failure in clinical practice.

Authors:  J G F Cleland
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

4.  Clinical burden and health service challenges of chronic heart failure.

Authors:  F D Richard Hobbs
Journal:  Br J Gen Pract       Date:  2010-08       Impact factor: 5.386

5.  Relationship between pulse transit time and blood pressure is impaired in patients with chronic heart failure.

Authors:  Daniel R Wagner; Norbert Roesch; Patrick Harpes; Heinrich Körtke; Pierre Plumer; Amir Saberin; Viviane Chakoutio; Denis Oundjede; Charles Delagardelle; Jean Beissel; Georges Gilson; Ingrid Kindermann; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2010-05-16       Impact factor: 5.460

Review 6.  Beta-blocker pharmacogenetics in heart failure.

Authors:  Jaekyu Shin; Julie A Johnson
Journal:  Heart Fail Rev       Date:  2008-04-24       Impact factor: 4.214

7.  [Cardiac resynchronization therapy. The electrophysiological contribution to the treatment of heart failure].

Authors:  J Potratz; U Wiegand
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

Review 8.  Progress toward genetic tailoring of heart failure therapy.

Authors:  John H Lillvis; David E Lanfear
Journal:  Curr Opin Mol Ther       Date:  2010-06

9.  Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.

Authors:  Joerg Honold; Ulrich Fischer-Rasokat; Florian H Seeger; David Leistner; Saskia Lotz; Stefanie Dimmeler; Andreas M Zeiher; Birgit Assmus
Journal:  Clin Res Cardiol       Date:  2013-04-24       Impact factor: 5.460

10.  Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice.

Authors:  Giorgio Costantino; Anna Maria Rusconi; Pier Giorgio Duca; Stefano Guzzetti; Ilaria Bossi; Marta Del Medico; Giuseppina Pisano; Mara Bulgheroni; Monica Solbiati; Raffaello Furlan; Nicola Montano
Journal:  Intern Emerg Med       Date:  2008-08-09       Impact factor: 3.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.